{
    "2021-02-08": [
        [
            {
                "time": "2021-02-08",
                "original_text": "恒瑞医药拟两千万美元投资璎黎药业，获抗肿瘤1类新药权益",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "璎黎药业",
                        "抗肿瘤",
                        "新药权益"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-02-08",
                "original_text": "HR20005凝胶的药物临床试验获批",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "HR20005",
                        "临床试验"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-02-08",
                "original_text": "恒瑞医药现3笔大宗交易，共成交100,430.85万元",
                "features": {
                    "keywords": [
                        "恒瑞医药",
                        "大宗交易"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-02-08",
                "original_text": "医药生物行业周报：第四批国采结果公布，长期看好创新与高景气细分领域",
                "features": {
                    "keywords": [
                        "医药生物",
                        "国采",
                        "创新",
                        "高景气"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-02-08",
                "original_text": "A股融资融券日报：两融余额减少113.4亿元（2月5日）",
                "features": {
                    "keywords": [
                        "A股",
                        "融资融券",
                        "两融余额"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}